Cocaine toxicity: Concurrent influence of dopaminergic, muscarinic and sigma receptors in mediating cocaine-induced lethality

Psychopharmacology

Volumn 129, Issue 4, 1997, Pages 311-321

  Ritz, Mary C ^a   George, Frank R ^a  

^a Amethyst Technologies Inc   (United States)

Author keywords

Cocaine; Dopamine; Muscarinic; Norepinephrine; Serotonin; Sigma

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMFEBUTAMONE; ATROPINE; CINANSERIN; COCAINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; N ALLYLNORMETAZOCINE; NEUROTRANSMITTER; PIRENZEPINE; PRAZOSIN; PROPRANOLOL; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; SPIPERONE; YOHIMBINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; LETHALITY; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RECEPTOR BINDING;

ANIMALS; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, DOPAMINE; RECEPTORS, MUSCARINIC; RECEPTORS, SIGMA;

EID: 0031049271     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050198     Document Type: Article

References (58)

1. Alburges ME, Narang N, Wamsley JK (1993) Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14:314-323
2. Bates CK (1988) Medical risks of cocaine use. West J Med 148:440-444
3. Bozarth M, Wise R (1985) Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat. JAMA 254:81-83
4. 3H]cocaine in striatum and its relationship to the dopamine transporter. Membr Biochem 7:87-106
5. Catravas JD, Waters IW (1981) Acute cocaine intoxication in the conscious dog: Studies on the mechanism of lethality. J Pharmacol Exp Ther 217:350-356
6. Ceci A, Smith M, French, ED (1988) Activation of the A10 mesolimbic system by the sigma receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic. Eur J Pharmacol 154:53-57
7. Cregler LL, Mark H (1986) Medical complications of cocaine abuse. N Engl J Med 315:1495-1500
8. Cubeddu LX, Hoffman IS, Talmaciu RK, Diliberto P, Lovemberg T (1991) Carbachol-phorbol ester interactions at muscarinic receptors modulating dopamine release from rabbit striatal slices. Neurosci Lett 131:245-248
9. 1 and N-methyl-D aspartate receptors. J Pharmacol Exp Ther 259:1064-1072
10. de Boer P, Damsma G, Fibiger HC, Timmerman W, de Vries JB, Westernick BHC (1990) Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain dialysis. Naunyn-Schmiedeberg's Arch Pharmacol 342:528-534
11. Derlet RW, Albertson TE, Rice P (1989) The effect of haloperidol in cocaine and amphetamine intoxication. J Emerg Med 7: 633-637
12. Derlet RW, Albertson TE (1990) Acute cocaine toxicity: antagonism by agents interacting with adrenoceptors. Pharmacol Biochem Behav 36:225-231
13. Derlet RW, Albertson TE, Rice P (1990a) The effect of SCH23390 against toxic doses of cocaine, d-amphetamine and methamphetamine. Life Sci 47:821-827
14. Derlet RW, Albertson TE, Rice P (1990b) Antagonism of cocaine, amphetamine, and methamphetamine toxicity. Pharmacol Biochem Behav 36:745-749
15. Dorje F, Wess J, Lambracht G, Tacke R, Mutschler E, Brann MR (1991) Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256: 727-733
16. Eidelberg E, Lesse H, Gault EP (1963) An experimental model of temporal lobe epilepsy: studies of the convulsant properties of cocaine. In: Glaser GH (ed) EEG and behavior. Basic Books, New York, pp 277-283
17. Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD (1994) Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Mol Pharmacol 46:1028-1035
18. Flynn DD, Vaishnav AA, Mash DC (1992) Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Mol Pharmacol 41:736-742
19. Garber MW, Flaherty D (1988) Cocaine and sudden death. Am Fam Phys 38:227-230
20. George FR (1991) Cocaine toxicity: genetic evidence suggests different mechanisms for cocaine-induced seizures and lethality. Psychopharmacology 104:307-311
21. 3H]dopaine release from rat striatal slices by sigma receptor ligands. J Pharmacol Exp Ther 271:212-219
22. Gradman AH (1988) Cardiac effects of cocaine: a review. Yale J Biol Med 61:137-147
23. 3H]-dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856
24. Graybiel AM, Besson M, Weber E (1989) Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sties in the substantia nigra, pars compacta of the cat. J Neurosci 6:1757-1770
25. Guo N, Robertson GS, Fibiger HC (1992) Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res 588:164-167
26. 1 receptors. J Pharmacol Exp Ther 266:557-562
27. Itzhak Y (1989) Multiple affinity binding states of the sigma receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol 36:512-517
28. Iyengar S, Dilworth VM, Mick SJ, Cantreras PC, Monahan JB, Rao TS, Wood PL (1990) Sigma receptors modulate both A9 and A10 dopaminergic neurons in the rat brain: functional interaction with NMDA receptors. Brain Res 524: 322-326
29. Izenwasser S, Newman AH, Katz JL (1993) Cocaine and several sigma receptor ligands inhibit dopamine uptake in rat caudate-putamen. Eur J Pharmacol 243:201-205
30. Jackson HC, Nutt DJ (1990) Noradrenergic mechanisms appear not to be involved in cocaine-induced seizures and lethality. Life Sci 47:353-359
31. Kennedy LT, Hanbauer I (1983) Sodium-sensitive cocaine binding to rat striatal membrane: possible relationship to dopamine uptake sites. J Neurochem 41:172-178
32. Koff JM, Shuster L, Miller LG (1994) Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther 268:277-282
33. Loper KA (1989) Clinical toxicology of cocaine. Med Toxicol Adverse Drug Exp 4:174-185
34. 3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141
35. 3H] 2B-carbomethoxy-3B-(4-fluoroplienyl) tropane. Mol Pharmacol 36:518-524
36. Mittleman RE, Wetli CV (1984) Death caused by recreational cocaine use: an update. JAMA 252:1889-1893
37. 3H-dopamine release from striatal synaptosomes: pharmacological characterization. J Neurochem 54:937-945
38. 3H]cocaine binding in brain is associated with serotonergic neurons. Mol Pharmacol 23:600-606
39. Ritz MC, George FR (1993) Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J Pharmacol Exp Ther 264:1333-1343
40. Ritz MC, George FR (1997) Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors. Psychopharmacology 129:299-310
41. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223
42. 2 receptor anonists on striatal acetylcholine release. J Pharmacol 219:323-325
43. Schindler CW, Tella SR, Witkin JM, Goldberg SR (1991) Effects of cocaine alone and in combination with haloperidol and SCH 23390 on cardiovascular function in squirrel monkeys. Life Sci 48:1547-1554
44. Sharkey J, Ritz MC, Sehenden JA, Hanson RC, Kuhar MJ (1988a) Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharmacol Exp Ther 246:1048-1052
45. Sharkey J, Glen KA, Wolfe S, Kuhar MJ (1988b) Cocaine binding at sigma receptors. Eur J Pharmacol 149:171-174
46. 3H]cocaine binding associated with dopamine uptake sites in the rat striatum and human putamen decrease after dopaminergic denervation and in Parkinson's disease. Naunyn-Schmiedeberg's Arch Pharmacol 329:227-235
47. Steinberg, D (1988) PROBIT: a supplementary module for SYSTAT and SYSGRAPH. SYSTAT Evanston, IL
48. Steinfels GF, Tam SW (1989) Selective sigma receptor agonist and antagonist affect dopamine neuronal activity. Eur J Pharmacol 163:167-170
49. Tella SR, Schindler CW, Goldberg SR (1990) The role of central and autonomic neural mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys. J Pharmacol Exp Ther 252:491-499
50. Terleckj I, Sonsalla PK (1994) The sigma receptor ligand (+)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors. J Pharmacol Exp Ther 269:44-50
51. Unterwald EM, Ho A, Rubenfeld JM, Kreek MJ (1994) Time course of the development of behavioral sensitixation and dopamine receptor up-regulation during binge cocaine administration. J Pharmacol Exp Ther 270:1387-1396
52. Wachtel SR, White FJ (1988) Electrophysiological effects of BMY 14802, a new potential antopsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies. J Pharmacol Exp Ther 244:410-416
53. Wamsley JR, Alburges ME (1993) Cocaine causes a time dependent and dose dependent increase in D1 receptors and dopamine transporters. Proc West Pharmacol Soc 36:277-282
54. Weiss F, Markou A, Lorang MT, Koob GF (1992a) Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318
55. Weiss F, Paulus MP, Lorang MT, Koob GF (1992b) Increases in extracellular dopamine in the nucleus accumbens by cocaine are inversely related to basal levels: effects of acute and repeated administration. J Neurosci 12:4372-4380
56. Wilkinson L (1987) SYSTAT: The system for statistics. SYSTAT Macintosh version 3.2 Evanston, IL
57. Wilson MC, Holbrook JM (1978) Intravenous cocaine lethality in the rat. Pharmacol Res Commun 10:243-256
58. Witkin JM, Goldberg SR, Katz JL (1989) Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist SCH 23390 but not by haloperidol. Life Sci 44:1285-1291